Monopar Therapeutics (MNPR) Common Equity (2016 - 2026)
Monopar Therapeutics (MNPR) recorded Common Equity of $130.85 million in Q2 2026, up 150.7% from $52.2 million a year earlier.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Common Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, Monopar Therapeutics reported Common Equity of $137.83 million, up 150.4% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of 54.4% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $55.04 million in FY2024 (+885.0%), $5.59 million in FY2023 (-44.6%), $10.09 million in FY2022 (-46.7%) and $18.94 million in FY2021 (+20.7%).
- Quarterly Common Equity has ranged from $4.95 million in Q3 2024 to $141.56 million in Q3 2025 over the past five years.
- On a year-over-year basis, Common Equity rose in five of the last six quarters, with growth averaging 422.5%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 885.0% in Q4 2024, against a decline of 47.3% in Q1 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Monopar Therapeutics | 715.17 Mn | 433.40 Mn | - | 130.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 130.85 Mn |
| Dec 31, 2025 | 137.83 Mn |
| Sep 30, 2025 | 141.56 Mn |
| Jun 30, 2025 | 52.20 Mn |
| Mar 31, 2025 | 53.59 Mn |
| Dec 31, 2024 | 55.04 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Jun 30, 2024 | 6.09 Mn |
| Mar 31, 2024 | 7.48 Mn |
| Dec 31, 2023 | 5.59 Mn |
| Sep 30, 2023 | 6.61 Mn |
| Jun 30, 2023 | 7.84 Mn |
| Mar 31, 2023 | 8.94 Mn |
| Dec 31, 2022 | 10.09 Mn |
| Sep 30, 2022 | 12.51 Mn |
| Jun 30, 2022 | 14.52 Mn |
| Mar 31, 2022 | 16.97 Mn |
| Dec 31, 2021 | 18.94 Mn |
| Sep 30, 2021 | 21.28 Mn |
| Jun 30, 2021 | 23.35 Mn |
API Access
Monopar Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MNPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();